HELB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.072400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.955000E-01
Normal-vs-Stage2
6.320600E-01
Normal-vs-Stage3
4.873600E-01
Normal-vs-Stage4
7.170600E-01
Stage1-vs-Stage2
4.810200E-01
Stage1-vs-Stage3
2.084800E-01
Stage1-vs-Stage4
9.318600E-01
Stage2-vs-Stage3
4.751800E-01
Stage2-vs-Stage4
6.316000E-01
Stage3-vs-Stage4
2.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.205600E-01
Normal-vs-AfricanAmerican
5.400000E-01
Normal-vs-Asian
4.082400E-01
Caucasian-vs-AfricanAmerican
7.832800E-01
Caucasian-vs-Asian
4.754100E-04
AfricanAmerican-vs-Asian
9.279900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.117800E-01
Normal-vs-Female
6.066200E-01
Male-vs-Female
9.322400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.798400E-01
Normal-vs-Age(41-60Yrs)
5.462000E-01
Normal-vs-Age(61-80Yrs)
5.544600E-01
Normal-vs-Age(81-100Yrs)
5.292600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.610600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.494400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.282000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.104200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.086800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.427400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.394400E-01
Normal-vs-Daily Drinker
5.151800E-01
Normal-vs-Weekly Drinker
4.841800E-01
Normal-vs-Occasional Drinker
6.738400E-01
Normal-vs-Social Drinker
6.516200E-01
Non Drinker-vs-Daily Drinker
7.674600E-01
Non Drinker-vs-Weekly Drinker
5.465800E-01
Non Drinker-vs-Occasional Drinker
2.598200E-01
Non Drinker-vs-Social Drinker
3.833800E-01
Daily Drinker-vs-Weekly Drinker
6.715000E-01
Daily Drinker-vs-Occasional Drinker
1.837560E-01
Daily Drinker-vs-Social Drinker
3.122200E-01
Weekly Drinker-vs-Occasional Drinker
1.481190E-01
Weekly Drinker-vs-Social Drinker
2.441800E-01
Occasional Drinker-vs-Social Drinker
8.269400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.219600E-01
Normal-vs-Grade 2
1.768230E-01
Normal-vs-Grade 3
7.725500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.633400E-01
Grade 1-vs-Grade 3
3.775600E-01
Grade 1-vs-Grade 4
2.219600E-01
Grade 2-vs-Grade 3
6.254200E-01
Grade 2-vs-Grade 4
1.768230E-01
Grade 3-vs-Grade 4
7.725500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.160000E-01
Normal-vs-NonDiabetic
5.612000E-01
Diabetic-vs-NonDiabetic
4.221000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.990400E-01
Normal-vs-NoPancreatitis
5.958200E-01
Pancreatitis-vs-NoPancreatitis
1.285220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.325800E-01
Normal-vs-N1
6.514800E-01
N0-vs-N1
6.239500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.890600E-01
Normal-vs-TP53-NonMutant
7.356000E-01
TP53-Mutant-vs-TP53-NonMutant
6.472000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
